Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval
Falanx Group Ltd (LON:FLX) Cyber Defence Executive Director Jay Abbott talks to DirectorsTalk about the set up of its new Falanx Cyber Technologies unit. Jay provides an update on how
Georgian Mining Corp (LON:GEO) Managing Director Greg Kuenzel talks to DirectorsTalk about the near surface intercepts from the first three drill holes at the Bolnisi Project in Georgia. Greg talks
KEFI Minerals Plc (LON:KEFI) Executive Chairman Harry Anagnostaras-Adams talks to DirectorsTalk about a conditional fundraising to raise £5.62m. Harry talks us through the announcement, explains why a new major institutional
Ascent Resources plc (LON:AST) CEO Colin Hitchinson talks to DirectorsTalk about its fund raise this weekend of £3m. Colin talks us through the fund raise and proceeds will be used
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the
Powerhouse Energy Group Plc (LON:PHE) Executive Chairman Keith Allaun talks to DirectorsTalk about the latest news from the company. Keith expands on the appointment of Waste2tricity as a Project Development
Morses Club Plc (LON:MCL) is the topic of discussion when Mark Thomas Analyst at Hardman and Co talks to DirectorsTalk. Mark explains whats attractive about the market its in, why
Versarien Plc (LON:VRS) CEO Neill Ricketts talks to DirectorsTalk about the launch of its new brand ‘Nanene’. Neill explains what it is, what it will be used for, other areas
OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced in January that it has had two abstracts accepted for
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
